REFLECTION 3-HOLE SHELL WITH ASYMMETRIC POROUS COATING

K060630 · Smith & Nephew, Inc. · LPH · Jun 14, 2006 · Orthopedic

Device Facts

• Record ID: K060630
• Device Name: REFLECTION 3-HOLE SHELL WITH ASYMMETRIC POROUS COATING
• Applicant: Smith & Nephew, Inc.
• Product Code: LPH · Orthopedic
• Decision Date: Jun 14, 2006
• Decision: SESE
• Submission Type: Abbreviated
• Regulation: 21 CFR 888.3358
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The REFLECTION 3-Hole Shell with Asymmetric Porous Coating is individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant. Hip components are also indicated for inflammatory degenerative joint disease including theumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, cr Girdlestone resection; fracture-dislocation of the hip; and correction of deformity. The REFLECTION 3-Hole Shell with Asymmetric Porous Coating is for single use only.

Device Story

Acetabular shell component for hip arthroplasty; titanium alloy construction with asymmetric porous coating; intended for primary or revision hip surgery. Device implanted by orthopedic surgeons in clinical/OR settings to replace damaged hip joint surfaces. Provides structural support for prosthetic hip components; facilitates bone ingrowth via porous coating. Single-use device.

Clinical Evidence

No clinical data.

Technological Characteristics

Titanium alloy shell with titanium porous coating; uncemented acetabular prosthesis; single-use; mechanical fixation.

Indications for Use

Indicated for patients undergoing primary or revision hip surgery due to trauma, noninflammatory degenerative joint disease (osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, pelvic fracture, diastrophic variant), inflammatory degenerative joint disease (rheumatoid arthritis, secondary arthritis, congenital dysplasia), remote osteomyelitis, nonunion, femoral neck/trochanteric fractures, endoprosthesis, femoral osteotomy, Girdlestone resection, fracture-dislocation, or deformity correction.

Regulatory Classification

Identification

A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement.

Predicate Devices

• REFLECTION Acetabular Shell

Submission Summary (Full Text)

{0}------------------------------------------------

K060630

## 510(K) Summary SMITH & NEPHEW REFLECTION 3-HOLE SHELL WITH ASYMMETRIC POROUS COATING

| SUBMITTER'S NAME: | Smith & Nephew, Inc., Orthopaedic Division |
|-----------------------------------|--------------------------------------------------------------------------------------------------------|
| SUBMITTER'S ADDRESS: | 1450 Brooks Road, Memphis, TN 38116 |
| SUBMITTER'S TELEPHONE NUMBER: | 901-399-5778 |
| CONTACT PERSON: | Katie Logerot |
| DATE SUMMARY PREPARED: | March 1, 2006 |
| TRADE OR PROPRIETARY DEVICE NAME: | REFLECTION 3-Hole Shell with Asymmetric Porous Coating |
| COMMON OR USUAL NAME: | Acetabular Shell |
| CLASSIFICATION NAME: | 21 CFR 888.3358 Hip joint metal/polymer/metal semi-<br>constrained porous-coated uncemented prosthesis |
| DEVICE CLASS: | Class II |
| PRODUCT CODE: | Orthopedics/87/MBL, LZO, LPH, JDI, MEH, LWJ |

### DEVICE INFORMATION:

#### A. INTENDED USE:

The REFLECTION 3-Hole Shell with Asymmetric Porous Coating is individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.

Hip components are also indicated for inflammatory degenerative joint disease including theumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, cr Girdlestone resection; fracture-dislocation of the hip; and correction of deformity.

The REFLECTION 3-Hole Shell with Asymmetric Porous Coating is for single use only.

#### DEVICE DESCRIPTION: B.

The REFLECTION 3-Hole Shell with Asymmetric Porous Coating is manufactured from titanium allov and has a titanium porous coating. The design of the shell is based upon the REFLECTION Acetabular Shell.

### C. SUBSTANTIAL EQUIVALENCE INFORMATION:

The substantial equivalence of the REFLECTION 3-Hole Shell with Asymmetric Porous Coating is supported by its similarities in design features, overall indications, and material composition to the REFLECTION Acetabular Shell manufactured and distributed by Smith & Nephew, Inc.

{1}------------------------------------------------

### D. SUMMARY OF TECHNOLOGICAL COMPARISON:

The intended use, design, and materials of the REFLECTION 3-Hole Shell with Asymmetric Porous Coating are substantially equivalent to the REFLECTION Acetabular Shell.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three lines representing its wings and a wavy line representing its body. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES U.S.A." written around the perimeter of the circle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN 1 4 2006

Smith & Nephew, Inc. Orthopaedic Division % Ms. Katie Logerot Regulatory Affairs Specialist II 1450 Brooks Road Memphis, Tennessee 38116

Re: K060630

Trade/Device Name: REFLECTION 3-Hole Shell with Asymmetric Porous Coating Regulation Number: 21 CFR 888.3358 Regulation Name: Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis Regulatory Class: II

Product Code: LPH, MBL, LZO, JDI, MEH, LWJ Dated: May 18, 2006 Received: May 19, 2006

Dear Ms. Logerot:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the enactment date of the Medical Device Amendments. or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA`s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act s requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): good manufacturing practice requirements as set

{3}------------------------------------------------

Page 2 - Ms. Katie Logerot

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely vours.

Barbara Buehrig

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

510(k) Number (if known): K060630

# Device Name: REFLECTION 3-Hole Shell with Asymmetric Porous Coating

Indications For Use:

The REFLECTION 3-Hole Shell with Asymmetric Porous Coating is indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis. fused hip, fracture of the pelvis, and diastrophic variant.

Hip components are also indicated for inflammatory degenerative joint disease including rheumatic arthrifis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral ne :: fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone researcr fracture-dislocation of the hip; and correction of deformity

The REFLECTION 3-Hole Shell with asymmetric porous coating is for single use only.

Prescription Use______________________________________________________________________________________________________________________________________________________________ (Per 21 CFR 801 109)

ાર

Over-The-Counter Use _

(Optional Format 1-2-96)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Jarlan huch

estorative. and Neurological D

510(k) **Number** K060630